Your browser doesn't support javascript.
loading
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
Capdevila, Jaume; Deandreis, Desiree'; Durante, Cosimo; Leboulleux, Sophie; Luster, Markus; Netea-Maier, Romana; Newbold, Kate; Singer, Susanne; Sykiotis, Gerasimos P; Bartes, Beate; Farnell, Kate; Locati, Laura Deborah.
Affiliation
  • Capdevila J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain.
  • Deandreis D; Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy.
  • Durante C; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Leboulleux S; Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland.
  • Luster M; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
  • Netea-Maier R; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Newbold K; Royal Marsden Hospital, London, United Kingdom.
  • Singer S; Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany.
  • Sykiotis GP; Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Bartes B; Association "Vivre sans Thyroïde", Léguevin, France.
  • Farnell K; Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK.
  • Locati LD; Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy.
Eur Thyroid J ; 12(5)2023 08 08.
Article in En | MEDLINE | ID: mdl-37429326
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Eur Thyroid J Year: 2023 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Eur Thyroid J Year: 2023 Document type: Article Affiliation country: España Country of publication: Reino Unido